CATHLEEN BROWN: Open Payments
NPI 1942773130 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 21 payments from 10 companies in 2025. Trend: 2023 $22 · 2024 $343 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Amgen Inc. | 4 | $67 |
| Novo Nordisk Inc | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $35 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: MOUNJARO, REPATHA, Kerendia, Ozempic, UBRELVY, AIRSUPRA, FREESTYLE LIBRE 3, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
